Clinical Trial Update: Trial of R-GemOx Regimen in Previously Untreated Elderly Patients With DLBCL. [Phase 2]

View source ↗

Summary

This entry reports a Phase 2 trial evaluating the Rituximab-Gemcitabine-Oxaliplatin (R-GemOx) regimen in previously untreated elderly patients with Diffuse Larg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)
• Rituximab (rituximab)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Diffuse Large B-cell Lymphoma | Phase 2 | Status: UNKNOWN